These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29657602)

  • 1. Guiding nanomaterials to tumors for breast cancer precision medicine: from tumor-targeting small-molecule discovery to targeted nanodrug delivery.
    Qu X; Qiu P; Zhu Y; Yang M; Mao C
    NPG Asia Mater; 2017; 9():. PubMed ID: 29657602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Blind" targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates.
    Galbiati E; Gambini L; Civitarese V; Bellini M; Ambrosini D; Allevi R; Avvakumova S; Romeo S; Prosperi D
    Pharmacol Res; 2016 Sep; 111():155-162. PubMed ID: 27293049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.
    Kim J; Potez M; She C; Huang P; Wu Q; Bao S; Rich JN; Liu JKC
    Stem Cells; 2023 Aug; 41(8):762-774. PubMed ID: 37280108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and Identification of Peptides Specifically Targeted to Gastric Cancer Cells from a Phage Display Peptide Library.
    Sahin D; Taflan SO; Yartas G; Ashktorab H; Smoot DT
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):927-932. PubMed ID: 29693344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
    Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
    Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage display screening of therapeutic peptide for cancer targeting and therapy.
    Saw PE; Song EW
    Protein Cell; 2019 Nov; 10(11):787-807. PubMed ID: 31140150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Strategy Utilizing Extracellular Cysteine-Rich Domain of Membrane Receptor for Constructing d-Peptide Mediated Targeted Drug Delivery Systems: A Case Study on Fn14.
    Li Z; Xie J; Peng S; Liu S; Wang Y; Lu W; Shen J; Li C
    Bioconjug Chem; 2017 Aug; 28(8):2167-2179. PubMed ID: 28715634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging.
    Chi YH; Hsiao JK; Lin MH; Chang C; Lan CH; Wu HC
    Theranostics; 2017; 7(6):1612-1632. PubMed ID: 28529640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel vascular-targeting peptide for gastric cancer delivers low-dose TNFα to normalize the blood vessels and improve the anti-cancer efficiency of 5-fluorouracil.
    Lu L; Li ZJ; Li LF; Shen J; Zhang L; Li MX; Xiao ZG; Wang JH; Cho CH
    Peptides; 2017 Nov; 97():54-63. PubMed ID: 28970092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Landscape phages and their fusion proteins targeted to breast cancer cells.
    Fagbohun OA; Bedi D; Grabchenko NI; Deinnocentes PA; Bird RC; Petrenko VA
    Protein Eng Des Sel; 2012 Jun; 25(6):271-83. PubMed ID: 22490956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homing peptide-conjugated gold nanorods: the effect of amino acid sequence display on nanorod uptake and cellular proliferation.
    Alkilany AM; Boulos SP; Lohse SE; Thompson LB; Murphy CJ
    Bioconjug Chem; 2014 Jun; 25(6):1162-71. PubMed ID: 24892190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-responsive multifunctional peptide coating of gold nanorods improves tumor targeting and photothermal therapy efficacy.
    Wu L; Lin B; Yang H; Chen J; Mao Z; Wang W; Gao C
    Acta Biomater; 2019 Mar; 86():363-372. PubMed ID: 30660006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.
    Wang T; D'Souza GG; Bedi D; Fagbohun OA; Potturi LP; Papahadjopoulos-Sternberg B; Petrenko VA; Torchilin VP
    Nanomedicine (Lond); 2010 Jun; 5(4):563-74. PubMed ID: 20528452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.
    Brown KC
    Curr Pharm Des; 2010; 16(9):1040-54. PubMed ID: 20030617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.
    Miller-Kleinhenz J; Guo X; Qian W; Zhou H; Bozeman EN; Zhu L; Ji X; Wang YA; Styblo T; O'Regan R; Mao H; Yang L
    Biomaterials; 2018 Jan; 152():47-62. PubMed ID: 29107218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a peptide by phage display for SPECT imaging of resistance-susceptible breast cancer.
    Larimer BM; Deutscher SL
    Am J Nucl Med Mol Imaging; 2014; 4(5):435-47. PubMed ID: 25143862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Killing of M2 Macrophages with Phage-Displayed Peptide-Photosensitizer Conjugates.
    Sioud M; Zhang Q
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
    Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
    Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-negative breast cancer targeting and killing by EpCAM-directed, plasmonically active nanodrug systems.
    Jenkins SV; Nima ZA; Vang KB; Kannarpady G; Nedosekin DA; Zharov VP; Griffin RJ; Biris AS; Dings RPM
    NPJ Precis Oncol; 2017; 1(1):27. PubMed ID: 29872709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.